SJIC
GSK icon

St. James Investment Company’s GSK GSK Stock Holding History

St. James Investment Company’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-4,919
Closed -$240K – 44
2018
Q1 		$240K Buy
+4,919
New +$229K 0.03% 41

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

St. James Investment Company's GSK Position: Q2 2018 in Review

St. James Investment Company sold out of GSK (GSK) in Q2 2018, closing a stake of 4,919 shares — an estimated $240K sold.

St. James Investment Company first reported a position in GSK in Q1 2018 and held it in 1 quarter. The position peaked at $240K in Q1 2018. 788 funds tracked by Wall St. Rank hold GSK as of Q2 2018.

  • St. James Investment Company reported no remaining GSK position as of Q2 2018 after selling out during the quarter.
  • St. James Investment Company sold 4,919 GSK shares in Q2 2018, an estimated $240K.
  • St. James Investment Company first reported a position in GSK in Q1 2018 and held it in 1 quarter.
  • St. James Investment Company's GSK position peaked at $240K in Q1 2018.
  • 788 funds tracked by Wall St. Rank held GSK as of Q2 2018.

Based on St. James Investment Company's 13F filing for Q2 2018, filed 13 Aug 2018.